$SABS
SAB Biotherapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateSAB Biotherapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is SABS up today? It is at $3.51 (+0.29%), and our scanner flagged it 10 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment SABS spikes, and full due diligence on SABS — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $SABS 10 times in the last 30 days. Create a free account to track $SABS, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on SABS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for SABS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Kropotova Alexandra Officer | Sold (automatic/other) | -473 | sold 1.1% | 42K | n/a | Sep 17, 26 |
Kropotova Alexandra Officer | Sold (automatic/other) | -988 | sold 2.3% | 42K | n/a | Jun 25, 26 |
Kropotova Alexandra Officer | Sold (automatic/other) | -988 | sold 2.2% | 43K | n/a | Mar 24, 26 |
Kropotova Alexandra Officer | Sold (automatic/other) | -988 | sold 2.2% | 44K | n/a | Dec 11, 25 |
Sessa Capital (Master), L.P. Director | Other | 1.74M 1.9% of company | added 100% | 2.20M | $3.0M at $1.75 | Sep 29, 25 |
Moin Andrew Director | Other | 1.74M 1.9% of company | added 100% | 2.20M | $3.0M at $1.75 | Sep 29, 25 |
Kropotova Alexandra Officer | Sold (automatic/other) | -2K | sold 4.2% | 45K | n/a | Sep 19, 25 |
Kropotova Alexandra Officer | Sold (automatic/other) | -1K | sold 2.4% | 47K | n/a | Mar 27, 25 |
Kropotova Alexandra Officer | Sold (automatic/other) | -9K | sold 16% | 48K | n/a | Dec 18, 24 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on SABS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for SABS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
SABS last traded at $3.51, up 0.29% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The SABS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged SABS 10 times in the last 30 days.
SABS (SAB Biotherapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $319M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge SABS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$SABS discussion
Sign in to ask a question or join the discussion.